Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):

October 31, 2005

 


 

OSI SYSTEMS, INC.

(EXACT NAME OF REGISTRANT SPECIFIED IN CHARTER)

 


 

CALIFORNIA   000-23125   330238801

(STATE OR OTHER JURISDICTION

OF INCORPORATION)

  (COMMISSION FILE NUMBER)  

(IRS EMPLOYER

IDENTIFICATION NO.)

 

12525 Chadron Avenue, Hawthorne, CA   90250
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (310) 978-0516

 

N/A

(Former name or former address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 1.01. Entry into a Material Definitive Agreement.

 

On October 31, 2005, OSI Systems, Inc. (the “Company”) completed the sale and delivery of approximately 20% of its equity interest in Spacelabs Healthcare, Inc. (“Spacelabs”), a newly formed Delaware corporation composed of the healthcare operations of the Company, to non-U.S. Persons (as such term is defined in Regulation S promulgated under the Securities Act of 1933, as amended). The offering raised approximately $27 million, net of expenses. The shares of common stock of Spacelabs are listed on the AIM of the London Stock Exchange under the ticker symbol “SLAB”.

 

In connection with the closing of the offering, the Company entered into a Master Intercompany Agreement, a Lock-In Agreement, a Placing Agreement and a Relationship Agreement with Spacelabs and various third-parties. A description of the terms and conditions of each agreement are set forth in the final admission document (the “Admission Document”) distributed to investors in connection with the offering. A copy of the Admission Document is attached as an exhibit to the Company’s Form 8-K filed on October 25, 2005 with the Securities and Exchange Commission.

 

Copies of the Master Intercompany Agreement, the Lock-In Agreement, the Placing Agreement and the Relationship Agreement are filed herewith as Exhibits 10.1, 10.2, 10.3 and 10.4, and are incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

10.1    Master Intercompany Agreement
10.2    Lock-In Agreement
10.3    Placing Agreement
10.4    Relationship Agreement


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

            OSI SYSTEMS, INC.

Date: November 4, 2005

     

By:

 

/s/ Victor Sze

               

Victor Sze

               

General Counsel


EXHIBIT INDEX

 

Exhibit
Number


  

Description


10.1    Master Intercompany Agreement
10.2    Lock-In Agreement
10.3    Placing Agreement
10.4    Relationship Agreement
Master Intercompany Agreement

Exhibit 10.1

 

MASTER INTERCOMPANY AGREEMENT

 

This Master Intercompany Agreement (this “Agreement”) is made and entered into by and between OSI Systems, Inc., a California corporation located at 12525 Chadron Avenue, Hawthorne, California (“OSI”) and Spacelabs Healthcare, Inc. a Delaware corporation with offices at 5150 220th Avenue SE, Issaquah, WA 98029 (“SHI”), effective as of October 24, 2005.

 

Recitals

 

WHEREAS, SHI and its subsidiaries on the one hand, and OSI and its subsidiaries (who are not SHI subsidiaries) on the other hand, from time to time require assistance from each other in administrative, operational, financial, manufacturing and other matters (each, a “Service” and collectively, the “Services”);

 

WHEREAS, the subsidiaries of SHI currently collectively owe to OSI an intercompany balance reflected on the books of the respective companies.

 

WHEREAS, OSI, SHI and their various subsidiaries are willing to provide such Services for each other in exchange for appropriate compensation; and

 

WHEREAS, the OSI and SHI each wish to set forth the framework for performance of such Services.

 

NOW, THEREFORE, THE PARTIES AGREE AS FOLLOWS:

 

Agreement

 

1. Identification of Parties. For purposes of this Agreement, the following definitions shall apply:

 

1.1. “OSI Group”. The “OSI Group” means OSI and its subsidiaries, other than SHI subsidiaries;

 

1.2. “SHI Group”. The “SHI Group” means SHI and its subsidiaries. A party’s subsidiary refers to an entity in which that party has a majority equity interest, measured by voting power; and

 

1.3. “Service Provider”. The party providing a Service shall be identified as a “Service Provider”.

 

1.4. “Service Recipient”. The party receiving a Service shall be identified as a “Service Recipient”.

 

2. Assignment within Groups. OSI may, in its discretion, cause some or all of its obligations under this Agreement to be performed, and permit some or all of its rights hereunder to be exercised, by any member of the OSI Group. SHI may, in its discretion, cause some or all of its obligations under this Agreement to be performed, and permit some or all of its rights hereunder to be exercised, by any member of the SHI Group. Each party agrees to

 

- 1 -


accept performance of any Service and the exercise of any other rights or obligations arising under this Agreement that have been so assigned, without requiring evidence of assignment.

 

3. Service Order. As a “master” form of contract, this Agreement allows the parties to contract for Services through the issuance of service orders without having to re-negotiate the basic terms and conditions contained herein. The specific details of a Service to be provided by a Service Provider under this Agreement shall be separately negotiated and specified in services orders substantially in the form attached hereto as Exhibit A. or as otherwise agreed in writing (each, a “Service Order”). Each Service Order will include, at a minimum, a description of the Service to be provided, the identity of the Service Provider and the Service Recipient, the term during which the Services will be provided, and the applicable fees and charges, as well as any requirements, considerations, or objectives which are in addition to the general provisions of this Agreement. Each Service Order shall be deemed to incorporate all of the terms and conditions of this Agreement. Notwithstanding the foregoing, OSI and SHI acknowledge and agree that some of the terms and conditions contained in this Agreement may not be applicable to every Service Order and that in such instances, such terms shall not apply. To the extent any terms or provisions of a Service Order conflict with the terms and provisions of this Agreement, the terms and provisions of the Service Order shall control. No Service Order shall be effective unless and until it is executed by an authorized representative of each party to such Service Order.

 

4. Services.

 

4.1. Space Allocation.

 

4.1.1. A Service Order relating to allocation of space shall set forth a description of the premises allocated, the duration of the allocation, the amount of any rent and other fees due for such allocation and applicable payment schedules. In the event the premises are leased by Service Provider from a third party, the Service Provider shall provide to Service Recipient a copy of the underlying lease between Service Provider and the landlord of the premises.

 

4.1.2. Service Recipient agrees and covenants to vacate the premises immediately upon termination or expiration of the underlying lease; not to make any alteration or addition to the premises without Service Provider’s consent (which shall not be unreasonably withheld or delayed); to leave the premises in as good as condition as when first occupied by Service Recipient (normal wear and tear excepted); and to comply in every respect with the provisions of any law and/or the underlying lease in respect to the premises. Service Provider covenants to permit Service Recipient to peaceably and quietly hold and enjoy the premises during the term of Service Recipient’s occupancy.

 

4.2. Support Services. Service Provider may provide administrative, IT or other support services for Service Recipient pursuant to a Service Order. Service Recipient agrees to reimburse Service Provider one hundred percent of Service Provider’s costs and out-of-pocket expenses, which shall include all direct costs incurred by Service Provider that are attributable to the employees directly engaged in providing the services (on a fully-burdened basis); all direct costs attributable to the materials and supplies consumed in rendering the Services; and any specifically-identifiable indirect costs that relate to the aforesaid direct costs, such as an allocable portion of occupancy costs, utilities, supervisory and clerical support, and

 

- 2 -


other overhead, general, and administrative costs (e.g., depreciation) reasonably allocable to a particular service or activity (collectively, “Costs”).

 

4.3. Financial Support and Tax Sharing. Both OSI and SHI agree, on their own behalves and on behalf of their respective subsidiaries, to mutually extend financial support and tax sharing arrangements to each other; provided however, that in the event OSI shall cease to own a majority of the combined voting power of the outstanding securities of SHI then, as of the date upon which OSI becomes such minority shareholder of SHI, no further mutual financial support or tax sharing shall occur between the parties. Such financial support from OSI to the SHI Group shall include access to additional working capital funds borrowed under OSI’s then-current banking credit facilities unless or until such time as SHI assets are not required to guarantee any of OSI’s obligations under such banking credit facilities. In the event that a Service Order provides for financial support or funding by OSI to the SHI Group, such Service Order shall be further evidenced by and made in accordance with the form of SHI Revolving Promissory Note, attached hereto as Exhibit B, or as otherwise agreed in writing. The opening balance under the SHI Revolving Promissory Note shall include the intercompany balance currently owed to OSI by SHI’s subsidiaries, as reflected on the books of the respective companies. In the event that a Service Order provides for financial support or funding by SHI to the OSI Group, such Service Order shall be further evidenced by and made in accordance with the form of OSI Revolving Promissory Note, attached hereto as Exhibit C, or as otherwise agreed in writing (collectively, the SHI Revolving Promissory Note and the OSI Revolving Promissory Note are referred to herein as the “Notes”). The Notes shall state the amount of the loan, the date made, the date payment is due, the payment schedule, the currency for repayment, any applicable grace period and the applicable interest rate. In the event that a Service Order provides for a tax sharing arrangement between OSI and SHI, such Service Order shall be further evidenced by and made in accordance with the terms of the form of Tax Sharing Agreement, attached hereto as Exhibit D, or as otherwise agreed in writing.

 

4.4. Manufacturing. SHI agrees to grant OSI preferred manufacturer status for products and manufacturing services required by SHI during the term of this Agreement as follows:

 

4.4.1. Submission of Manufacturing Proposal. If SHI requires the manufacture of a product or component, or manufacturing services, of a type that the OSI Group is capable of providing, SHI shall notify OSI of such requirement. SHI shall then provide OSI an opportunity to bid on such requirement on terms no less favorable to OSI than terms provided to other bidders with respect to that requirement.

 

4.4.2. Acceptance of Manufacturing Proposal. SHI shall provide OSI the right to manufacture such product or component or provide such services if (i) OSI’s proposal meets the delivery, quality, regulatory and documentation requirements for such product or component; and (ii) the pricing offered by OSI (including tax, shipping and insurance) is no more than 5% more than the lowest quotation provided by a competitor for such product or component or services supplied on comparable terms. In the event that OSI’s proposal complies with section 4.4.2 (i) but not 4.4.2 (ii), SHI shall advise OSI of same and provide an opportunity for OSI to revise the pricing in its proposal.

 

4.4.3. Purchase by SHI. In the event OSI’s proposal meets the above conditions, SHI shall purchase such product or component from OSI under SHI’s standard purchase order terms and conditions, setting forth the product description and specifications,

 

- 3 -


quantity of product to be manufactured and delivered to SHI, timeframe for delivery of such product, and the price to be paid for the product.

 

4.5. Other. The parties may enter into such other intercompany arrangements as they may from time to time agree in writing.

 

5. Fees. For the Services provided under a Service Order, Service Recipient shall pay Service Provider the fees detailed in the Service Order. Such fees shall be based on Service Recipient’s use of Service Provider’s Services as agreed upon at the execution of the Service Order. Any request for alteration, substitution or change from such agreed Services will be evaluated on an individual basis and may be subject to additional charges if mutually agreed by the parties.

 

6. Payment. Except as otherwise provided in a Service Order, Service Provider will issue monthly invoices for the amounts payable by Service Recipient pursuant to a Service Order. Each invoice shall be payable thirty (30) days from the date of the invoice, in U.S. dollars, at the address set forth in the Service Order.

 

7. Arm’s Length Pricing. Both Service Provider and Service Recipient intend to adhere to the arm’s length standard set forth in section 482 of the United States Internal Revenue Code and related regulations. Accordingly, the parties to a Service Order shall periodically review the rate of compensation for services provided under a Service Order. If any changes to the rate are determined by the mutual agreement of Service Provider and Service Recipient, then they shall execute an appropriate amendment to the Service Order.

 

8. Proprietary Rights. It is recognized and understood that the existing inventions and technologies of Service Provider and Service Recipient are their separate property, respectively, and are not affected by this Agreement. Neither party shall at any time during or after the term of this Agreement have any ownership rights relating to or emanating from any intellectual property (including, but not limited to designs, trademarks, trade names, web sites, know-how, other intangible property, or other related matters) of the other, other than licenses necessary to enable the contemplated manufacture, sale or use of products manufactured hereunder. The parties shall mutually agree as to the ownership of all intellectual property rights with respect to works, inventions and discoveries made during the course of performing Services.

 

9. Confidentiality. In the performance of this Agreement or any Service Order hereunder, a party may disclose (“Discloser”) to the other party (“Recipient”) certain Confidential Information of Discloser. The term “Confidential Information” shall mean (i) any business or technical information which the Discloser regards as confidential and in which it claims a proprietary interest or (ii) information which by its nature would generally be considered as confidential. Such Confidential Information includes, without limitation, financial data, plans such as business plans, marketing plans, and product development plans, customer data, research results, product design data, and manufacturing methods, specifications or materials, which is/are owned, controlled or possessed by Discloser in either written, oral or visual form. Recipient shall hold Confidential Information of Discloser in confidence and shall not use, without the prior written consent of Discloser, such Confidential Information for any purpose other than in the performance of this Agreement or a Service Order.

 

- 4 -


10. Warranty. Service Provider warrants that its Services will be free of material defects and performed in a professional and workmanlike manner. If Service Provider manufactures products hereunder, Service Provider warrants that, upon delivery, such products will be free from material defects and will perform in accordance with the specifications set forth in the applicable Service Order.

 

11. Remedies and Limitations. Service Provider’s obligations and liabilities under Section 10 (Warranty) shall be limited, at Service Provider’s option, to (i) reperformance of any Services necessary to correct the defect(s) discovered, (ii) repayment of or reduction in a reasonable portion of the fees paid by Service Recipient for Services covered by the Service Order, or (iii) in the case of any products delivered hereunder, repair or replacement at the option of Service Provider. EXCEPT AS EXPRESSLY STATED IN THIS SECTION 11, SERVICE PROVIDER MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR IMPLIED WARRANTY ARISING FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USAGE OF TRADE. SERVICE PROVIDER SHALL NOT BE LIABLE TO SERVICE RECIPIENT FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES, COVER, OR ANY LOSS OF INFORMATION, PROFIT, REVENUE OR USE RESULTING FROM BREACH OF WARRANTY OR ANY OTHER PROVISION OF THIS AGREEMENT.

 

12. Limitation of Liability. Service Provider’s liability (whether in tort, contract or otherwise, and notwithstanding any fault, negligence, strict liability or product liability of Service Provider) with regard to any Services or product provided under a Service Order will in no event exceed the total compensation paid by Service Recipient to Service Provider under such Service Order.

 

13. Term and Termination. This Agreement shall remain in effect until August 31, 2015. Following this initial term, this Agreement will be renewed automatically for successive 12-month periods, unless it is terminated by (i) a mutual written agreement of OSI and SHI or (ii) by either party giving written notice to the other party at least 30 days prior to the beginning of the next term.

 

14. Notices. All notices and other communications shall be considered given and effective when personally delivered or when mailed, postage prepaid, to the recipient’s principal offices, to the attention of recipient’s chief executive officer, or to such other addresses as the parties may designate in writing.

 

15. Independent Contractor; Authority. Service Provider’s relationship with Service Recipient is that of an independent contractor, and Service Provider shall have sole control over the performance of all Services to be performed by it hereunder and of all of its employees, agents, and contractors engaged in performing such services. Neither OSI nor SHI shall have the right to assume or create any obligation of any kind, either express or implied, on behalf of the other, except as expressly provided for in this Agreement or in another written agreement between the parties. Nothing in this Agreement shall be deemed to establish or otherwise create a relationship of principal and agent, employer and employee, or otherwise between Service Provider and Service Recipient.

 

16. Assignment. Neither party shall assign all or any part of this Agreement, or any given Service Order(s) hereunder, or any of its rights hereunder or thereunder without the other

 

- 5 -


party’s prior written consent, which shall not be unreasonably withheld; save that either party may assign rights and responsibilities as set forth in Section 2 of this Agreement.

 

17. Nonwaiver. The failure of either OSI or SHI to insist upon or enforce strict performance by the other of any of the provisions of this Agreement, or any given Service Order(s) hereunder, or to exercise any rights or remedies under this Agreement, or any given Service Order(s) hereunder, will not be construed as a waiver or relinquishment to assert or rely upon any such provisions, rights or remedies in that or any other instance; rather the same will remain in full force and effect.

 

18. Compliance with Laws. OSI and SHI shall comply, and OSI shall ensure members of the OSI Group, and SHI shall ensure that members of the SHI Group that are acting as Service Providers comply, with all laws, regulations, rules, orders and other requirements that are applicable to their respective performances under this Agreement or under any Service Order.

 

19. Excused Performance. Neither Service Provider nor Service Recipient will be liable for, or be considered to be in breach of or default under this Agreement, or any given Service Order, on account of any delay or failure to perform as required by this Agreement, or any given Service Order, if a result of any causes or conditions beyond such party’s reasonable control, including but not limited to: fires; acts of God or the elements; acts, delays and failures to act by civil, military or other governmental authority; labor disputes; riots, sabotage or war; or breakdown or destruction of any equipment, facilities or other property.

 

20. Counterparts. This Agreement may be executed in counterparts, each of which will be an original, but each of which together will constitute one instrument. OSI and SHI each agree that a photocopy or facsimile signature to this Agreement shall be treated for all purposes as an original signature.

 

21. Severability. In the event any provision, clause, sentence, phrase, or word in this Agreement, or the application thereof in any circumstances, is held to be invalid or unenforceable, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement, or of the application of any such provision, sentence, clause, phrase, or word in any other circumstances.

 

22. Governing Law. This Agreement shall be governed by and interpreted in accordance with the laws of the State of California, USA, without reference to its laws relating to conflicts of law. Any legal action arising out of or relating to this Agreement shall be brought only in the state and federal courts located in Los Angeles County, California, and the parties irrevocably consent to the jurisdiction and venue of such courts.

 

23. Dispute Resolution Procedure. In the event of a dispute arising out of or relating to this Agreement, OSI and SHI agree to negotiate diligently and in good faith to resolve such dispute. If such negotiation does not resolve the dispute, OSI and SHI shall appoint members of their respective senior management to address the dispute. If consultation by respective senior management representatives does not result in a resolution, OSI and SHI shall appoint members of their respective Boards of Director to consult with respect to the dispute. All disputes remaining unresolved thirty (30) days after the appointment of Board of Director representatives may be submitted by either OSI or SHI for final settlement in accordance with the commercial arbitration rules of the Judicial Arbitration and Mediation Service (“JAMS”)

 

- 6 -


prevailing at the time (“the Rules”); provided, however, that in the event of a conflict between the Rules and this Agreement, the latter shall control. The arbitration will be conducted by a single arbitrator with industry-specific experience to be mutually agreed upon by the parties pursuant to the Rules. Judgment on the award rendered by the arbitrator may be entered in any court of competent jurisdiction.

 

24. Entire Agreement. This Agreement, along with all Service Orders entered into hereunder, constitutes the entire agreement, and supersedes any and all prior agreements, between OSI and SHI with regard to the Services which are the subject of the applicable Service Orders entered into under this Agreement. No amendment, modification or waiver of any of the provisions of this Agreement, or any given Service Order(s) hereunder, will be valid unless set forth in writing, signed by an authorized representative of both OSI and SHI.

 

OSI Systems, Inc.

     

Spadelabs Healthcare, Inc.

By:

 

/s/ Deepak Chopra

     

By:

 

/s/ Victor Sze

Name:

 

Deepak Chopra

     

Name:

 

Victor Sze

Title:

 

Director

     

Title:

 

Company Secretary

 

- 7 -

Lock-In Agreement

Exhibit 10.2

 

DATED 24 October 2005

 

OSI SYSTEMS, INC.

UDT SENSORS, INC

 

and

 

COLLINS STEWART LIMITED

 

and

 

SPACELABS HEALTHCARE, INC.

 

Lock-In and Orderly Marketing Agreement

in relation to Spacelabs Healthcare, Inc.

 

LOGO

 

Adelaide House London Bridge London EC4R 9HA

tel +44 (0) 20 7760 1000 fax +44 (0) 20 7760 1111


Contents

 

1    Interpretation    1
2    Restrictions    3
3    Time of Essence    5
4    Waiver    6
5    Invalidity and Severability    6
6    Notices    6
7    Counterparts    8
8    Entire Agreement    8
9    Assignment    8
10    Third Party Rights    9
11    Governing Law and Jurisdiction    9


THIS AGREEMENT is made on 24 October, 2005

 

BETWEEN:

 

1 OSI SYSTEMS, INC of 12525 Chadron Ave, Hawthorne CA 90250 USA and UDT SENSORS, INC of 12525 Chadron Ave, Hawthorne CA 90250 USA (each a “Covenantor”); and

 

2 COLLINS STEWART LIMITED whose registered office is at 9th Floor, 88 Wood Street, London EC2V 7QR (the “Nominated Adviser”); and

 

3 SPACELABS HEALTHCARE, INC. whose registered office is at 5150 220th Avenue SE, Issaquah, Washington 98029, USA (the “Company”).

 

RECITALS:

 

(A) The Company wishes to raise additional funds by the issue of Common Stock for cash and desires to obtain the admission to trading on AIM of its Common Stock issued and to be issued pursuant to the Placing.

 

(B) The Covenantors are the registered and beneficial holder of Common Stock.

 

(C) The Covenantors have agreed with the Nominated Adviser to enter into certain restrictions with regard to the disposal by it of the Shares held by it in anticipation of the Nominated Adviser acting as nominated adviser and broker to the Company following Admission.

 

THE PARTIES AGREE AS FOLLOWS:

 

1 Interpretation

 

1.1 The following provisions of this clause shall have effect for the interpretation of this agreement.

 

1


1.2 The following words and expressions shall, unless the context otherwise requires, have the following meanings:

 

Act

   means Companies Act 1985;

Admission

   means the admission to trading on AIM of the whole of the issued Common Stock of the Company (as enlarged by the Placing), and a reference to “becoming effective” is to be construed in accordance with rule 6 of the AIM Rules;

Admission Document

   means the document in the agreed form proposed to be published on behalf of the Company in connection with the Company’s application to be made to the London Stock Exchange for Admission as required by rule 3 of the AIM Rules;

AIM

   means AIM, a market operated by the London Stock Exchange;

AIM Rules

   means the rules published by the London Stock Exchange governing admission to AIM and the regulation of AIM companies as amended or reissued from time to time;

Business Day

   means a day (excluding Saturdays, Sundays and public holidays) on which banks are open for normal banking business in the City of London;

Common Stock

   the shares of common stock in the capital of the Company with par value $0,001 each;

London Stock Exchange

   means London Stock Exchange pic;

Placing

   means the proposed placing by the Nominated Adviser of new Common Stock in accordance with the placing agreement entered into by the Nominated Adviser and the Company (amongst others) and as more particularly described in the Admission Document; and

U.S. Reporting Company

   a company that issues securities in an offering registered under the Securities Act of 1933, as amended, or is required to register a class of its outstanding securities under the Securities Exchange Act of 1934, as amended.

 

1.3 In this agreement, unless otherwise specified, reference to:

 

  1.3.1 “includes” and “including” shall mean including without limitation;

 

  1.3.2 

a “subsidiary undertaking” or “parent undertaking” is to be construed in accordance with section 258 of the Act and a “subsidiary” or “holding company” is to be construed in accordance with section 736 of the Act and an “associated company” is to be construed in

 

2


 

accordance with section 416 et seq. of the Income and Corporation Taxes Act 1988;

 

  1.3.3  a party means a party to this agreement and includes the successors in title to that part of its undertaking which includes this agreement and, in the case of an individual, to his or her estate and personal representatives;

 

  1.3.4  recitals, clauses, paragraphs or schedules are to recitals, clauses and paragraphs of and schedules to this agreement. The schedule forms part of the operative provisions of this agreement and references to this agreement shall, unless the context otherwise requires, include references to the recitals and the schedules;

 

  1.3.5 words denoting the singular shall include the plural and vice versa and words denoting any gender shall include all genders; and

 

  1.3.6 the time of the day is reference to time in London, England.

 

1.4 The index to and the headings in this agreement are for information only and are to be ignored in construing the same.

 

2 Restrictions

 

2.1 In consideration of the Nominated Adviser and the Company entering into arrangements in relation to the Placing and procuring Admission, the Covenantors hereby undertake to the Nominated Adviser and the Company:

 

  2.1.1  not at any time prior to the first anniversary of the date of Admission without the prior written consent of the Nominated Adviser, to offer, dispose of, or agree to offer or dispose of, directly or indirectly, any Common Stock or any interest in any Common Stock or other shares in the capital of the Company or any securities convertible into or exchangeable for Common Stock or other shares in the capital of the Company (including any Common Stock resulting from the exercise of options issued or to be issued by the Company); or

 

  2.1.2

 not at any time prior to the first anniversary of the date of Admission without the prior written consent of the Nominated Adviser, to enter into or agree to enter into any derivative transaction of any type whatsoever (including, without limitation, any swap, contract for

 

3


 

differences, option, warrant or futures transaction or arrangement) in respect of, or referenced to, the sale or disposal of any Common Stock or other shares in the capital of the Company, whether any such transaction is settled by delivery of Common Stock or other securities, in cash or otherwise; or

 

  2.1.3  in order to preserve an orderly market in the Common Stock, not to take any action described in clauses 2.1.1 or 2.1.2 above at any time in the period commencing on the first anniversary of the date of Admission and ending on the date of the second anniversary of Admission (the “Relevant Period”), except through the Nominated Adviser (or such other broker appointed by the Company from time to time) as the agent selling stockbroker (subject to (i) the Company’s broker’s duty to provide “best excecution” as required under the applicable rules of the UK Financial Services Authority’s “Conduct of Business Sourcebook”; and (ii) the Company’s broker charging a market rate of commission);

 

  2.1.4  in the event that a Covenantor wishes to take any action described in clauses 2.1.1 and 2.1.2 above during the Relevant Period in relation to a transfer of common stock to a third party in a private transaction (not arranged by the Nominated Adviser), the Nominated Adviser’s consent shall be required (such consent not to be unreasonably withheld or delayed) provided that the transferee agrees by deed in a form to be approved by the Nominated Adviser (such consent not to be unreasonably withheld) to be bound by provisions of clause 2.1.3. In the event of such transfer no commission shall be payable to the Nomad.

 

In this clause 2.1 “dispose” includes mortgaging, pledging, charging, lending, assigning, selling, transferring or otherwise disposing of the relevant securities.

 

2.2 The provisions of clause 2.1.3 shall cease to have effect upon the Company effecting a dual listing of the Company or listing on any other recognised investment exchange (including, for the avoidance of doubt, NASDAQ) or in the event of the Company becoming a US Reporting Company.

 

4


2.3 The provisions of clause 2.1 shall not apply:

 

  2.3.1  to an acceptance of, or pursuant to the provisions of an undertaking to accept, a general offer made to all shareholders of the Company to acquire Common Stock by a person who is not acting in concert with the Covenantor (a “Third Party Offer”);

 

  2.3.2  to the giving of an irrevocable undertaking to accept a Third Party Offer;

 

  2.3.3  to selling any Common Stock to a person making a Third Party Offer or a person who has announced an intention to make a Third Party Offer;

 

  2.3.4  to making a counter-bid following a Third Party Offer;

 

  2.3.5  pursuant to any scheme of reconstruction in relation to the Company;

 

  2.3.6  upon an intervening court order which has not been obtained with the consent of the Covenantor; or

 

  2.3.7  to any body corporate which is a member of a group (as defined in section 262 of the Companies Act 1985) of which the Covenantor is then a member, provided that:

 

  2.3.7.1  the transfer is made off-market;

 

  2.3.7.2  the transferee agrees by deed in a form approved by the Company’s broker to be bound by the provisions of clause 2.1; and

 

  2.3.7.3  if the transferee ceases to be a member of the same group as the Covenantor, then the Covenantor must procure that such Common Stock transferred are promptly transferred back to the Covenantor or to another member of its group.

 

3 Time of Essence

 

Save as otherwise expressly provided in this agreement, time is of the essence to every obligation of this agreement and any agreement amending or substituting its terms.

 

5


4 Waiver

 

4.1 A waiver of any term, provision or condition of, or consent granted under, this agreement shall be effective only if given in writing and signed by the waiving or consenting party and then only in the instance and for the purpose for which it is given.

 

4.2 No failure or delay on the part of any party in exercising any right, power or privilege under this agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power or privilege preclude any other or further exercise thereof or the exercise of any other right, power or privilege.

 

4.3 No breach of any provision of this agreement shall be waived or discharged except with the express written consent of the parties.

 

4.4 The rights and remedies herein provided are cumulative with and not exclusive of any rights or remedies provided by law.

 

5 Invalidity and Severability

 

5.1 If any provision of this agreement is or becomes (whether or not pursuant to any judgment or otherwise) invalid, illegal or unenforceable in any respect under any law of any jurisdiction:

 

  5.1.1  the validity, legality and enforceability under the law of that jurisdiction of any other provision;

 

  5.1.2  the validity, legality and enforceability under the law of any other jurisdiction of that or any other provision,

 

  5.1.3  shall not be affected or impaired in any way thereby.

 

5.2 If any provision of this agreement shall be held to be void or illegal, invalid or unenforceable, in whole or in part, for any reason whatsoever, such provision or part shall to that extent be deemed not to form part of this agreement but the legality, validity and enforceability of the remaining provisions of this agreement shall not be affected.

 

6 Notices

 

6.1

Any notice, demand or other communication given or made under or in connection with the matters contemplated by this agreement shall be in writing and shall be

 

6


 

delivered personally or sent by facsimile or prepaid first class post (air mail if posted to or from a place outside the United Kingdom):

 

in the case of the Covenantors to:

 

Name:    OSI Systems, Inc and UDT Sensors, Inc respectively
Address:    12525 Chadron Avenue, Hawthorne CA 90250, USA
Fax:    310 970 0862
Attention:    CEO, Copy to General Counsel

 

in the case of the Company to:

 

Name:    Spacelabs Healthcare, Inc.
Address:    12525 Chadron Avenue, Hawthorne CA 90250, USA
Fax:    310 970 0862
Attention:    CEO, Copy to General Counsel

 

in the case of Nominated Adviser to:

 

Name:    Collins Stewart Limited
Address:    9th Floor, 88 Wood Street, London EC2V 7QR
Fax:    + 44 20 7523 8131
Attention:    Mr. Tim Mickley

 

and shall be deemed to have been duly given or made as follows:

 

  6.1.1  if personally delivered, upon delivery at the address of the relevant party;

 

  6.1.2  if sent by first class post, two Business Days after the date of posting;

 

  6.1.3  if sent by air mail, five Business Days after the date of posting; and

 

  6.1.4  if sent by facsimile, when despatched,

 

provided that if, in accordance with the above provision, any such notice, demand or other communication would otherwise be deemed to be given or made after

 

7


5.00 p.m. such notice, demand or other communication shall be deemed to be given or made at 9.00 a.m. on the next Business Day.

 

6.2 A party may notify the other parties to this agreement of a change to its name, relevant addressee, address or facsimile number for the purposes of clause 6.1 provided that such notification shall only be effective:

 

  6.2.1  on the date specified in the notification as the date on which the change is to take place; or

 

  6.2.2  if no date is specified or the date specified is less than five Business Days after the date on which notice is given, the date falling five Business Days after notice of any such change has been given.

 

7 Counterparts

 

7.1 This agreement may be executed in any number of counterparts which together shall constitute one agreement. Any party may enter into this agreement by executing a counterpart and this agreement shall not take affect until it has been executed by all parties.

 

7.2 Delivery of an executed counterpart of a signature page by facsimile transmission shall take effect as delivery of an executed counterpart of this agreement. If such method is adopted, without prejudice to the validity of such agreement, each party shall provide the others with the original of such page as soon as reasonably practicable thereafter.

 

8 Entire Agreement

 

8.1 Each of the parties acknowledges and agrees with the other parties that this agreement constitutes the entire and only agreement and understanding between the parties in relation to its subject matter.

 

8.2 This agreement may be varied only by a document signed by each party.

 

9 Assignment

 

No party to this agreement may assign, transfer or charge all or any of any other party’s obligations nor any of its rights or benefits arising under this agreement without the prior written consent of all the other parties.

 

8


10 Third Party Rights

 

The Contracts (Rights of Third Parties) Act 1999 shall not apply to this agreement and no rights or benefits expressly or impliedly conferred by it shall be enforceable under that Act against the parties to it by any other person but this does not affect any right or remedy of a third party which exists or is available apart from that Act.

 

11 Governing Law and Jurisdiction

 

11.1 This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of or in any way relating to this agreement or its formation) shall be governed by and construed in accordance with English law.

 

11.2 Each of the parties to this agreement irrevocably agrees that the courts in England shall have exclusive jurisdiction to hear and decide any suit, action or proceedings, and/or to settle any disputes, which may arise out of or in connection with this agreement (respectively, “Proceedings” and “Disputes”) and, for these purposes, each party irrevocably submits to the jurisdiction of the courts of England.

 

11.3 Nothing in this clause shall (or shall be construed so as to) limit the right of the Nominated Adviser to take Proceedings against the Company or the Covenantors in the courts of any country in which any of the Company or the Covenantors have assets or in any other court of competent jurisdiction, nor shall the taking of Proceedings in any one or more jurisdictions preclude the taking of proceedings in any other jurisdiction (whether concurrently or not), if and to the extent permitted by applicable law.

 

11.4 Without prejudice to any other permitted mode of service the parties agree that service of any claim form, notice or other document (“Documents”) for the purpose of any Proceedings begun in England shall be duly served upon it if delivered or sent by registered post, in the case of:

 

  11.4.1  the Covenantors to the CEO at OSI Systems, Inc. 12525 Chadron Avenue, Hawthorne, CA 90250 USA and the CEO at UDT Sensors Inc 12525 Chadron Avenue, Hawthorne, CA 90250 USA;

 

  11.4.2  the Company to the Company (marked for the attention of the CEO Spacelabs Healthcare, Inc 12525 Chadron Avenue, Hawthorne, CA 90250 USA); and

 

9


  11.4.3  the Nominated Adviser to Collins Stewart Limited at, 9th Floor, 88 Wood Street, London EC2V 7QR (marked for the attention of Mr. Tim Mickley),

 

or such other person or address in England and/or Wales as the Company or the Covenantor shall notify the Nominated Adviser in writing or vice versa from time to time. Nothing contained in this clause 11.4 affects the right to serve process in another manner permitted by law.

 

10


IN WITNESS whereof this agreement has been executed and delivered on the date first above written.

 

Executed as a deed by SPACELABS HEALTHCARE, INC. acting by:    )   

/s/ Nikhil Mehta


   )   
     )   
          Director
          Director/Secretary

 

Signed by Philip P. Roe

   )     
     )     
for and on behalf of COLLINS STEWART LIMITED:    )   

/s/ Philip P. Roe


   )     

 

SIGNED AND DELIVERED AS A DEED by OSI Systems, Inc., a company incorporated in USA acting by Deepak Chopra Victor Sze (being a person(s) who, in accordance with the laws of that territory, is/are acting under the authority of the company) in the presence of:        

Sign here

     

/s/ Deepak Chopra


       
     

/s/ Victor Sze


       
     

Authorised signatory (or signatories)

 

Witness: Signature  

/s/ David Amzallag

Name

 

David Amzallag

Address

 

110 Cannon St

   

London

Occupation

 

Solicitor

 

SIGNED AND DELIVERED AS A DEED by UDT Sensors, Inc., a company incorporated in USA, acting by Deepak Chopra Victor Sze (being a person(s) who, in accordance with the laws of that territory, is/are acting under the authority of the company) in the presence of:        

Sign here

     

/s/ Deepak Chopra


       
     

/s/ Victor Sze


       
     

Authorised signatory (or signatories)

 

Witness: Signature  

/s/ David Amzallag

Name

 

David Amzallag

Address

 

110 Cannon St

   

London

Occupation

 

Solicitor

 

11

Placing Agreement

Exhibit 10.3

 

DATED 24 October 2005

 

SPACELABS HEALTHCARE, INC.

 

THE DIRECTORS OF SPACELABS, INC.

 

OSI SYSTEMS, INC.

 

COLLINS STEWART LIMITED

 

PLACING AGREEMENT

 

in respect of

 

SPACELABS HEALTHCARE, INC.

 

LOGO

 

Adelaide House London Bridge London EC4R 9HA

tel +44 (0) 20 7760 1000 fax +44 (0) 20 7760 1111


CONTENTS

 

1    Definitions and interpretation    2
2    Conditions    10
3    Delivery of documents    12
4    Application for Admission    12
5    Placing Shares    13
6    Placing    14
7    Pre-admission and post-admission obligations    15
8    Warranties    19
9    Indemnities    21
10    Termination    25
11    Fees, commissions and expenses    26
12    Undertakings re overseas securities laws    28
13    Announcements    29
14    Variation and waiver    29
15    Time of the essence    29
16    Law and jurisdiction    29
17    Notices    30
18    Invalidity    31
19    Counterparts    31
20    Survivorship    31
21    Entire agreement    31
22    Assignment    31
23    Contracts (Rights of Third Parties) Act 1999    31
24    General    32


DATED 24 October 2005

 

PARTIES

 

1

   Company    SPACELABS HEALTHCARE, INC. a corporation incorporated under the laws of the State of Delaware, USA;

2

   Directors    THE SEVERAL PERSONS whose names and addresses are set out in Schedule 1 parts 1 and 2;

3

   OSI    OSI SYSTEMS, INC a corporation incorporated under the laws of the State of California, USA; and

4

   Nomad    COLLINS STEWART LIMITED (company no 01774003) whose registered office is at 9th Floor, 88 Wood Street, London EC2V 7QR.

 

RECITALS

 

(A) The Company was incorporated under the laws of the State of Delaware, USA on 2 August 2005 as a company limited by shares. Details of the Company’s shares of common stock are set out in part 7 of the Admission Document.

 

(B) The Company proposes to raise approximately £16.83 million (before expenses) by way of a placing of new Ordinary Shares at the Placing Price.

 

(C) An application is proposed to be made to the London Stock Exchange for the entire issued and to be issued shares of common stock of $0.001 each in the capital of the Company to be admitted to trading on AIM.

 

(D) Nomad has agreed as agent for the Company to use its reasonable endeavours to procure subscribers for the Placing Shares and, failing which, to subscribe for the Placing Shares itself on the terms and subject to the Conditions set out in this Agreement.

 

(E) OSI (together with a wholly owned subsidiary of OSI, UDT Sensors, Inc.) currently owns all of the shares of common stock of the Company and will retain a holding of approximately 80 per cent. in the Company on Admission.

 

1


(F) Nomad has agreed to enter into this Agreement in reliance, inter alia, on the representations, warranties, indemnities and undertakings contained in this Agreement.

 

(G) The Placing is to be made outside the United States within the meaning of and pursuant to Regulation S.

 

OPERATIVE PROVISIONS

 

1 Definitions and interpretation

 

1.1 In this Agreement unless the context requires otherwise the following definitions apply:

 

Accountants’ Long Form Report    the accountants’ long form report on the Group dated 19 October 2005 prepared by the Reporting Accountants;
Accountants’ Short Form Report(s)    the accountants’ short form reports on:
     (i) the Company for the period from the date of incorporation to the Accounts Date; and
     (ii) the Group (other than the Company) for the period from 1 July 2004 to the Accounts Date,
     in each case prepared by the Reporting Accountants and contained in the Admission Document;
Accounts Date    30 June 2005 in respect of the Group (other than the Company) and 31 August 2005 in respect of the Company;
Act    the Companies Act 1985 (as amended);
Admission    admission of all of the Ordinary Shares (issued and to be issued pursuant to the Placing) to trading on AIM becoming effective in accordance with rule 6 of part 1 of the AIM Rules;

 

2


Admission Document    the document, being the document in the agreed terms numbered 1 in Schedule 4, prepared in accordance with the AIM Rules;
Agreement    this agreement;
AIM    the market of that name operated by the London Stock Exchange;
AIM Rules    the AIM Admission Rules as issued by the London Stock Exchange;
Application    the application to be made by the Company in accordance with rule 5 of part 1 of the AIM Rules;
Board Minutes    the minutes of the meeting of the board of Directors in the agreed terms numbered 3 in Schedule 4;
Business Day    a day (excluding Saturday, Sunday and statutory holidays) when clearing banks in England and Wales are open for business;
Company’s Solicitors    Kirkpatrick & Lockhart Nicholson Graham LLP of 110 Cannon Street, London EC4N 6AR;
Completion Date    the date on which Admission becomes effective;
Conditions    the conditions contained in clause 2.1;
CREST    the relevant system (as defined in the CREST Regulations) in respect of which CRESTCO is the Operator (as defined in the CREST Regulations);
CREST Regulations    the Uncertificated Securities Regulations 2001 (SI 2001 no 3755);
CRESTCO    CRESTCo Limited;

 

3


Directors    the directors of the Company whose names and addresses are set out in Schedule 1;
Directors’ Responsibility Letters    the documents in the agreed terms numbered 2 in Schedule 4, being the letters from each of the Directors confirming their responsibility for the Admission Document;
Estimate of Expenses    the schedule of expenses in the agreed terms numbered 4 in Schedule 4 in respect of the expenses of advisers to the Group and to Nomad;
Executive Directors    those directors of the Company whose names are set out in Schedule 1 part 1;
FSA    the Financial Services Authority;
FSMA    the Financial Services and Markets Act 2000;
Group    the Company and each of its Subsidiaries from time to time (which shall for the avoidance of doubt include all companies whose shares are beneficially owned by the Company immediately following the Re-organisation);
Indemnified Persons    Nomad and any subsidiary, subsidiary undertaking or holding company of Nomad, any division of Nomad, and any subsidiary or subsidiary undertaking of such holding company, and the current and former directors, officers, employees and agents of each of such persons;
Indemnities    the indemnities set out or referred to in clause 9;

 

4


Legal Due Diligence Report(s)    the legal due diligence reports relating to the Group prepared by: (i) the Company’s Solicitors in respect of Spacelabs Medical UK Limited, Blease Medical Holdings Ltd dated 23 September 2005; and (ii) Loeb & Loeb LLP in respect of Dolphin Medical, Inc., Spacelabs Medical, Inc. and the Company dated 9 September 2005;
London Stock Exchange    London Stock Exchange plc;
Nominated Adviser and Broker Agreement    the agreement between the Company, the Directors, OSI and Nomad in the agreed terms numbered 9 in Schedule 4;
Non-Executive Directors    the non-executive directors of the Company whose names are set out in Schedule 1 part 2;
Ordinary Shares    shares of common stock of US$0.001 each in the capital of the Company;
Placees    persons to be procured by Nomad to subscribe for Placing Shares pursuant to the provisions of this Agreement;
Placing    the placing of the Placing Shares by Nomad pursuant to this Agreement and the Placing Documents;
Placing Documents    together the Admission Document and the Placing Letter;
Placing Letter    the letter and form of confirmation in the agreed terms numbered 9 in Schedule 4 to be sent by Nomad on behalf of the Company to Placees in relation to the Placing;
Placing Price    125 pence per Placing Share;
Placing Shares    the 13,461,756 new Ordinary Shares to be issued by the Company and subscribed for pursuant to clause 5;

 

5


Power of Attorney    a power of attorney in the agreed terms numbered 5 in Schedule 4 to be given by each of the Directors;
Press Announcement    the press announcement in the agreed terms numbered 6 in Schedule 4 relating to the Placing;
Registrars    the Company’s registrars being Computershare Investor Services Limited (Channel Islands), PO Box No 83, Ordnance House, 31 Pier Road, St Helier, Jersey JE4 8PW;
Regulation S    Regulation S promulgated under the US Securities Act;
Relationship Agreement    the relationship agreement between the Company and OSI in the agreed terms numbered 10 in Schedule 4;
Re-organisation    as defined in paragraph 23 of Schedule 2;
Reporting Accountants    Deloitte & Touche LLP, Athene Place, 66 Shoe Lane, London EC4A 3BQ;
Solicitors to the Placing    Berwin Leighton Paisner of Adelaide House, London Bridge, London EC4R 9HA;
Subsidiary    as defined in section 736 of the Act and includes subsidiary undertakings as defined in section 258 of the Act and Subsidiaries’ will be construed accordingly;
Supplementary Admission Document    any supplementary admission document prepared in accordance with clause 4.3;

 

6


Tax or Taxation    all taxes, levies, imposts, duties, contributions, deductions, charges and withholdings of whatsoever nature whenever and wherever imposed by a Taxation Authority or pursuant to fiscal legislation and without prejudice to the generality of the foregoing includes:
    

(a)    within the United Kingdom, income tax, corporation tax, capital gains tax, value added tax, HM Revenue & Customs duties, advance corporation tax, inheritance tax, social security contributions, stamp duty, stamp duty reserve tax and amounts corresponding to any of the foregoing;

    

(b)    outside the United Kingdom, identical or substantially similar taxes to those United Kingdom taxes referred to above together with all other taxes on gross and net income, profits or gains, receipts, sales, use, occupation, franchise, added value and personal property; and

    

(c)    all penalties, charges, surcharges, fines and other similar amounts and interest included in or relating to any of the above regardless of whether such taxes or other matters referred to in paragraph (a) are directly or primarily chargeable against or attributable to a member of the Group or any other person, firm or company and regardless of whether a member of the Group has or may have any right of reimbursement against any other person;

Taxation Authority    any authority, whether of the United Kingdom or elsewhere, competent to impose, assess or collect Taxation, including but not limited to the Board of Inland Revenue, the Commissioners of HM Revenue & Customs and the Department of Social Security;

 

7


United States    has the meaning given to it in Regulation S;
US Securities Act    the United States Securities Act of 1933 (as amended);
VAT    United Kingdom value added tax;
Verification Notes    the document in the agreed terms numbered 7 in Schedule 4, being the questions prepared by the Company’s Solicitors for the purpose of verifying the statements and information in the Admission Document together with the answers to such questions, signed by or initialled on behalf of each of the Directors;
Warranties    the warranties contained in clause 8 and Schedule 2; and
Working Capital Report    the report dated 19 October 2005 prepared by the Reporting Accountants on the working capital projections in respect of the Group for period to 30 June 2007.

 

1.2 In this Agreement:

 

  1.2.1  words and phrases, the definitions of which are contained or referred to in the Act, have the meanings given to them therein (unless otherwise expressly defined in this Agreement);

 

  1.2.2  any reference to a statutory provision includes a reference to:

 

  1.2.2.1  any order, regulation, statutory instrument or other subsidiary legislation at any time made under it for the time being in force (whenever made); and

 

8


  1.2.2.2  any modification, amendment, consolidation, re-enactment or replacement of it or any provision of which it is a modification, amendment, consolidation, re-enactment or replacement;

 

provided that the incorporation of a reference to any such new legislation or modifications, amendments, consolidations, re-enactments or replacements coming into force after the date hereof shall not increase the liability of any party hereunder as a result of such interpretation;

 

  1.2.3  reference to a clause, Schedule or paragraph is to a clause of or a Schedule to or paragraph of a Schedule to this Agreement respectively;

 

  1.2.4  the Schedules form part of this Agreement and will have the same force and effect as if expressly set out in the body of this Agreement;

 

  1.2.5  reference to any document being “in the agreed terms” is to that document in the form signed or initialled by or on behalf of the Company and Nomad for identification. A list of documents in the agreed terms is set out in Schedule 4;

 

  1.2.6  references to times of the day are to London times;

 

  1.2.7  words denoting persons include bodies corporate, unincorporated associations and partnerships and vice versa;

 

  1.2.8  reference to any professional firm or company includes any firm or company effectively succeeding to the whole, or substantially the whole, of its practice or business;

 

  1.2.9  unless the context otherwise requires, words denoting the singular shall include the plural and vice versa and words denoting a gender shall include each other gender; and

 

  1.2.10  headings are for ease of reference only and do not affect the construction or interpretation of this Agreement.

 

9


2 Conditions

 

2.1 The obligations of Nomad under this Agreement are conditional upon satisfaction of each of the following conditions by the relevant time and/or date referred to below:

 

  2.1.1  the delivery to Nomad of an electronic copy of the Admission Document on the date of this Agreement;

 

  2.1.2  the release of the Press Announcement through a Regulatory Information Service of the London Stock Exchange by not later than 8.00 am on the date following the date of this Agreement;

 

  2.1.3  the delivery by the Company to Nomad simultaneously with the execution of this Agreement (or immediately thereafter if the context requires) of each of the documents specified in Schedule 5 (except as may be otherwise agreed by Nomad);

 

  2.1.4  the Company and the Directors having confirmed in writing in the form of the certification set out in Schedule 6 to Nomad that immediately prior to Admission there has not come to their attention (having made due and careful enquiry) any matter, fact, circumstance or event which renders any of the Warranties untrue or inaccurate in any material respect (or which would render any of the Warranties untrue or inaccurate in any material respect if then repeated) by reference to the facts subsisting at that time such certificate to be treated as delivered and effective as at 5.00 pm on the Business Day immediately prior to Admission;

 

  2.1.5  the Placing Shares having been allotted, subject only to Admission in the manner described in clause 5.3;

 

  2.1.6  there not having arisen or occurred before Admission any material new factor, mistake or inaccuracy relating to the information included in the Admission Document such that a Supplementary Admission Document is required by the AIM Rules to be published unless a supplementary document has been published in accordance with clause 4.3; and

 

  2.1.7  Admission taking place not later than 8.00 am on 31 October 2005 or such later date as is agreed in writing between the Company and Nomad, but in any event not later than 8.00 am on 8 November 2005.

 

10


In the event of any non-fulfilment of any of such conditions or any matter, fact, circumstance or event arising or occurring which would or might result in any of such conditions being incapable of being fulfilled, the Company shall forthwith give notice to Nomad of the circumstances of such non-fulfilment or potential non-fulfilment.

 

2.2 The Company and the Directors jointly and severally agree to use their respective reasonable endeavours (in the case of the Directors, subject to their fiduciary duties), to procure the fulfilment of the Conditions set out in clause 2.1 by the times and dates stated in clause 2.1. If any of the Conditions have not been fulfilled on or before the time and date set for its fulfilment or becomes incapable of being fulfilled (subject to Nomad not exercising its rights under clause 2.3 to waive or extend the time for fulfilment of the relevant condition), this Agreement and everything contained in it shall (save as provided below) cease and determine provided that until such time as any such conditions shall become incapable of being fulfilled or shall be waived by Nomad, each of the parties hereto shall comply with the obligations on its or his part contained in this Agreement for the purpose of implementing the Placing. In that event, none of the parties shall have any claim against any other party whatsoever in respect of this Agreement provided that:

 

  2.2.1  the provisions of clause 1, this clause 2.2, clauses 9, 13 and 16 to 24 shall remain in full force and effect;

 

  2.2.2  the Company shall pay the incidental costs referred to in clause 11.2;

 

  2.2.3  all monies received from Placees pursuant to the Placing shall be returned to such Placees at their own risk; and

 

  2.2.4  such termination shall be without prejudice to any accrued rights or obligations of any party under this Agreement.

 

2.3 Nomad may, in its absolute discretion, waive or extend the time for fulfilment of all or any or any part of any of the Conditions set out in clause 2.1 by notice in writing to the Company save that such time shall not be extended beyond 8 November 2005.

 

11


3 Delivery of documents

 

3.1 Each of the Company and the Directors will procure that there is communicated or delivered to Nomad all such information and documents (signed by the appropriate person where so required) as Nomad may reasonably require to enable it to discharge its obligations under this Agreement and pursuant to the Placing.

 

3.2 The Directors and the Company will procure that the documents stated in the Admission Document as being available for inspection will be made so available to Nomad.

 

4 Application for Admission

 

4.1 The Company confirms that it has authorised Nomad to make the Application on its behalf and undertakes that it will pay all such fees as may be necessary to obtain Admission not later than 8.00 am on 31 October 2005 or such later date as is agreed in writing between the Company and Nomad, but in any event not later than 8 November 2005.

 

4.2 The Company and each of the Directors undertake to take all such steps, execute all such documents and provide all such information, give all such undertakings and do or procure to be done all such things as may be necessary to comply with the requirements of the AIM Rules and the London Stock Exchange in connection with the Application.

 

4.3 Without prejudice to the provisions of clause 10, where, after publication of the Admission Document (but before Admission), there arises or is noted any material new factor, mistake or inaccuracy relating to the information included in the Admission Document, each of the Directors undertakes to notify the Company immediately after becoming aware of the same (whether or not such information results in any Warranty becoming untrue or inaccurate) and the Company will immediately:

 

  4.3.1  disclose the factor, mistake or inaccuracy to Nomad in writing; and

 

  4.3.2  in consultation with Nomad, prepare a Supplementary Admission Document and procure the publication of the same; and

 

  4.3.3  following publication of any Supplementary Admission Document, make available free of charge sufficient copies of such document in accordance with the requirements of the AIM Rules.

 

12


4.4 If a Supplementary Admission Document is published pursuant to clause 4.3, reference to the Admission Document or to the Placing Documents in clauses 9 and 10 shall be deemed to include the Supplementary Admission Document and the Warranties referred to in clause 8 and set out in Schedule 2 shall be deemed to have been made and given in relation to the Admission Document as amended and supplemented by the Supplementary Admission Document as well as to the original Admission Document.

 

4.5 Subject to compliance by the Company and the Directors with clauses 4.1 to 4.3 (inclusive) and to their providing Nomad with all such information and assistance as it may reasonably require to carry out its obligations under this clause 4.5, Nomad will extend to the Company all such assistance in connection with the fulfilment of the Conditions generally and, in particular, the issue of the Admission Document, the Application, the Placing and, where relevant (and without prejudice to its rights under clause 10), compliance with the AIM Rules and the publication of a Supplementary Admission Document if any as is reasonable and consistent with its obligations and duties as nominated adviser (as defined in the AIM Rules) to the Company.

 

5 Placing Shares

 

5.1 On the terms and subject to the conditions referred to in this Agreement and the Placing Documents and in reliance, inter alia, on the warranties, indemnities and undertakings contained in this Agreement, Nomad agrees to use its reasonable endeavours to procure subscribers for the Placing Shares at the Placing Price by the distribution of the Placing Documents and on the basis of the information contained therein only and, in the event that subscribers are not obtained for all or any of the Placing Shares at the Placing Price, Nomad (or such other company (being within the same group of companies as Nomad) as Nomad shall nominate) will subscribe, as principal and at the Placing Price, for all of those Placing Shares in respect of which subscribers have not been obtained.

 

5.2 The Company irrevocably appoints and instructs Nomad to act as its agent for the purposes of the Placing. The appointment confers on Nomad, on behalf of the Company, all powers, authorities and discretions which are reasonably necessary for or incidental to the Placing and the Company agrees to ratify and confirm everything which Nomad shall lawfully do or have done in the proper and reasonable exercise of such powers, authorities and discretions. Nomad accepts such appointment on those terms.

 

13


5.3 The Company shall procure that the board of Directors (or a duly authorised committee of the board) shall allot the Placing Shares, subject to the certificate of incorporation, the by-laws and other constitutional documentation of the Company and conditional on this Agreement becoming unconditional and not being terminated in accordance with its terms, to such persons in certificated form and in such denominations as may be notified to it by Nomad pursuant to clause 6.1 and on the terms that, on such allotment becoming unconditional, such shares shall be fully paid and shall rank pari passu in all respects with all other Ordinary Shares then in issue, including the right to receive all dividends and other distributions declared, made or paid after the date of their issue.

 

5.4 The subscription price for each of the Placing Shares shall be the Placing Price, the aggregate of which Nomad shall procure to be paid (in cleared funds) (less the deductions made pursuant to clause 11 in respect of fees, commissions and costs payable by the Company) out of the proceeds of the Placing received by Nomad by no later than 3.00 pm on the third Business Day after the Completion Date by telegraphic transfer to the account of the Company with Bank of America, ABA number 026009593, account number 67107- 409.

 

5.5 The receipt by the Company of the amount referred to in clause 5.4 shall constitute an absolute discharge of any obligation to Nomad to make payment to the Company in respect of the Placing Shares and Nomad shall not be required to investigate the application of such amount.

 

5.6 The Placing Shares shall be subscribed for free from all liens, charges, encumbrances, equities and other third party rights of any nature whatever with all rights of any nature whatever attaching or accruing to them now or after the date of their issue.

 

6 Placing

 

6.1. Following performance by the Company of its obligations pursuant to clauses 2 and 3, and subject to the terms and conditions of this Agreement and the Placing Letter, Nomad will, as agent for the Company:

 

  6.1.1  effect the Placing by procuring the despatch of the Placing Letters and, using reasonable endeavours, seek to procure subscribers for the Placing Shares at the Placing Price;

 

  6.1.2 

procure that all monies received pursuant to the Placing are kept in an interest-bearing bank account held in the name of Nomad until

 

14


 

payment to the Company in accordance with clause 5.4 (Nomad shall not be required to place any such monies or to procure that any such monies are placed on deposit); and

 

  6.1.3  as soon as practicable, supply to the Company a schedule of Placees (showing their full names and addresses) subscribing for the Placing Shares pursuant to the Placing and the number of Placing Shares for which they are each subscribing.

 

6.2 In accordance with the Placing Documents Nomad will determine in its absolute discretion:

 

  6.2.1  the identity of the subscribers for the Placing Shares;

 

  6.2.2  the validity or otherwise of acceptances received for Placing Shares under the Placing; and

 

  6.2.3  the basis of allocation of Placing Shares under the Placing.

 

6.3 If by 12.00 noon on the Business Day immediately prior to the day of Admission the Company and Nomad after consultation with the Registrars determine pursuant to procedures maintained under the Money Laundering Regulations 2003 that satisfactory evidence as to identity has not been, and is unlikely to be, received within a reasonable period of time in respect of any acceptances received for Placing Shares under the Placing, the Placing Shares comprised in that acceptance will not be allocated to any such person and Nomad will use its reasonable endeavours to procure Placees for any such Placing Shares prior to Admission and in the event that Placees are not procured for any such Placing Shares at the Placing Price prior to Admission, Nomad will subscribe, as principal and at the Placing Price, for all those Placing Shares in respect of which subscribers have not been obtained.

 

7 Pre-admission and post-admission obligations

 

7.1 Registration

 

  7.1.1 

The Company and the Directors severally undertake to Nomad that they shall promptly after the allotment of the Placing Shares becomes unconditional procure the registration (without registration fee) as members of the Company of the Placees of the Placing Shares and procure the issue to such persons registered as members of the

 

15


 

Company, not later than the date specified therefor in the timetable set out in the Admission Document, of definitive share certificates in respect of the Placing Shares to which they are entitled.

 

  7.1.2  The Company will provide the Registrars with all necessary authorisations and information to enable the Registrars to perform their duties as registrars in accordance with and as contemplated by this Agreement, the terms of the Placing Documents and any agreement between the Registrars and the Company.

 

7.2 Use of Placing proceeds

 

The Company hereby undertakes that it will, and each of the Directors severally undertakes to Nomad to use all reasonable endeavours to procure that the Company will, apply sums realised pursuant to the placing of the Placing Shares only for the purposes set out in the Admission Document.

 

7.3 Restrictions on transfer of shares by Directors

 

  7.3.1  Each of the Directors undertakes to Nomad in consideration of Nomad entering into this Agreement that save with the prior written consent of Nomad (in its absolute discretion), for the period commencing on the date of this Agreement and ending on the first anniversary of the Completion Date, (the “Hard Lock In Expiry Date”), he will not:

 

  7.3.1.1  offer, dispose of or agree to offer or dispose of, directly or indirectly, any Ordinary Shares or any interest in any Ordinary Shares or other shares in the capital of the Company or any securities convertible into or exchangeable for Ordinary Shares or other shares in the capital of the Company (including any Ordinary Shares resulting from the exercise of options issued or to be issued by the Company); or

 

  7.3.1.2  enter into or agree to enter into any derivative transaction of any type whatsoever (including, without limitation, any swap, contract for differences, option, warrant or future transaction or arrangement) in respect of, or referenced to, any Ordinary Shares or other shares in the capital of the Company, whether any such transaction is settled by delivery of Ordinary Shares or other securities, in cash or otherwise.

 

16


In this clause 7.4 “dispose” includes mortgaging, pledging, charging, lending, assigning, selling, transferring or otherwise disposing of the relevant securities.

 

7.3.2  The provisions of clause 7.4 shall not apply:

 

  7.3.2.1  pursuant to an intervening court order; or

 

  7.3.2.2  in acceptance of a general offer made to shareholders of the Company to acquire all the Ordinary Shares (other than any such shares which are already owned by the person making such offer or any person(s) acting in concert with it which has been recommended by the Directors or which has become or been declared unconditional in all respects) or the execution and delivery of an irrevocable commitment or undertaking to accept a general offer (without any further agreement to transfer or dispose of any shares or any interest therein) such as is mentioned above; or

 

  7.3.2.3  for a disposal by the personal representatives of any of the Directors who shall die during the period referred to above provided that the sale or other disposal of any shares in the Company by such personal representatives pursuant to this clause 7.3.2.3 during such period shall be effected in consultation with Nomad so as to ensure an orderly market for the issued share capital of the Company; or

 

  7.3.2.4  to a spouse, son, daughter, stepson or stepdaughter; or

 

  7.3.2.5  for the purpose only of effecting the appointment of a new trustee or by the trustees of a trust to a person beneficially entitled under such trust; or

 

  7.3.2.6  pursuant to any compromise or arrangement providing for the acquisition by any person (or group of persons acting in concert) of 50% or more of the equity share capital of the Company which has been recommended by the Directors; or

 

17


  7.3.2.7  pursuant to any scheme of reconstruction in relation to the Company;

 

provided always that:

 

  7.3.2.8  any transferee as is referred to in clause 7.3.2.3, 7.3.2.4 or 7.3.2.5 undertakes to Nomad by deed in a form reasonably acceptable to Nomad to comply with all liabilities and obligations of the transferor under this Agreement, whereupon the transferor will be released from any such liability or obligation; and

 

  7.3.2.9  Nomad is given notice in writing by the relevant Director(s) prior to effecting any disposal or agreement for disposal pursuant to clause 7.3.2.4 or 7.3.2.5.

 

  7.3.3  Subject to the terms of clause 7.3.1, each of the Directors hereby covenants and undertakes to Nomad that, in order to preserve an orderly market in the Ordinary Shares and subject to having first obtained Nomad’s written consent to any such sales (such consent not to be unreasonably withheld), he will for a period commencing on the Hard Lock In Expiry Date and ending on the first anniversary thereof effect any sales of Ordinary Shares, or procure that any such sales are effected, through Nomad or the Company’s broker from time to time (subject to (i) Nomad’s or the Company’s broker’s duty (as the case may be) to provide “best excecution” as required under the applicable rules of the UK Financial Services Authority’s “Conduct of Business Sourcebook”; and (ii) Nomad or the Company’s broker (as the case may be) charging an equivalent rate of commission to that charged by it to similar clients at the relevant time).

 

7.4 CREST

 

If, subsequent to the date of this Agreement it becomes possible as a result of a change in law, a “no action letter” addressed to AIM by the US Securities and Exchange Commission, or for any other reason, for the settlement of the Ordinary Shares to be effected through CREST (or another similar system for paperless settlement of trades) without the Company, the transferors or the transferees of

 

18


such shares breaching any of the requirements of Regulation S, the Company and the Directors undertake to Nomad to use reasonable endeavors to enable the Ordinary Shares to be settled through CREST (or the relevant other system for paperless settlement of trades) including arranging for the holders of the Ordinary Shares to transfer their Ordinary Shares to a depositary and for the depositary to issue those holders with depositary interests representing their Ordinary Shares.

 

7.5 Bank Facility

 

The Directors, the Company and OSI undertake to Nomad to use their reasonable endeavours following Admission to negotiate new banking facilities for the Group and the related release of the existing obligations of, and security granted by, members of the Group pursuant to OSI’s current banking arrangements with Bank of the West.

 

8 Warranties

 

8.1 Subject to clause 8.11, the Company and each of the Executive Directors jointly and severally warrant to Nomad (for itself and for the benefit of the holders of Placing Shares) in the terms of Schedule 2. Each of the Non-Executive Directors severally warrants to Nomad (for itself and for the benefit of the holders of Placing Shares) in the terms of Schedule 2 so far as each Non-Executive Director is aware of the facts relating to each such warranty other than paragraphs 17.1, 17.3 and 18 of Schedule 2 where the warranties are given in relation to himself only but without any awareness qualifications. Subject to clause 8.11, OSI warrants to Nomad (for itself and for the benefit of the holders of Placing Shares) in the terms of paragraph 9 and 23 of Schedule 2. The Warranties shall remain in full force and effect notwithstanding Admission.

 

8.2 The Company, OSI and each of the Directors acknowledge that Nomad has relied on the Warranties in entering into this Agreement. Each of the Warranties shall be construed as a separate warranty and shall not be limited by the terms of any other of the Warranties or by any other term of this Agreement.

 

8.3

Where any of the Warranties is qualified (or in the case of the Non-Executive Directors only and in accordance with clause 8.1, is deemed to be qualified) by an expression of awareness, knowledge, information or belief, that Warranty shall be deemed to include an additional statement that it has been made after due and careful enquiry by the persons giving that Warranty into the subject matter of that

 

19


 

Warranty and the awareness, knowledge, information or belief of any one of those persons shall be imputed to the remaining persons.

 

8.4 If at any time prior to Admission:

 

  8.4.1  any breach of any of the Warranties or any matter, fact, circumstance or event which could give rise to such a breach shall come to the knowledge of the Company, OSI or of any Director; or

 

  8.4.2  any matter, fact, circumstance or event shall come to the knowledge of the Company, OSI or any Director which, if the Warranties were repeated at such time, would render the Warranties untrue or inaccurate,

 

it or he will give immediate notice to Nomad of the same upon becoming aware of such breach, matter, fact, circumstance or event.

 

8.5 No claim in respect of any breach of any of the Warranties shall be brought (and none of the Company, OSI or any of the Directors shall be liable under the Warranties in respect of any breach) if the fact, event or circumstance giving rise to the breach has been disclosed in the Admission Document or any Supplementary Admission Document which may be required to be published.

 

8.6 Neither the Company nor any of the Directors shall be liable for any claim under the Warranties unless written notice of the claim (giving reasonable details of the basis of such claim) is served on it/ him by Nomad not later than one month after publication of the audited consolidated accounts of the Group in respect of the financial year ending 30 June 2007 and either the amount payable in respect of the relevant claim has been agreed between the relevant parties to this Agreement or legal proceedings have been instituted in respect of the relevant claim and served on the relevant parties within six months of service of such written notice.

 

8.7 The liability of the Directors under the Warranties shall (save in the case of fraud or wilful concealment by the relevant party) be limited so that no Director shall be individually liable for an amount in excess of the amount set opposite his name in column 2 of Schedule 3.

 

8.8 The liability of each of the Company and OSI under the Warranties and clause 8.11 shall (save in the case of fraud or wilful concealment by the relevant party) be limited so that neither corporation shall be individually liable for an amount in excess of the amount set opposite its name in column 2 of Schedule 3.

 

20


8.9 None of the information supplied by the Company or its officers or employees or its professional advisers to the Directors or their agents, representatives or advisers in connection with the Warranties or otherwise in relation to the business affairs of the Group shall be deemed a representation, warranty or guarantee of its accuracy by the Company or such officers, employees or professional advisers to the Directors and the Directors waive any claims against the Company which they might otherwise have in respect of the same.

 

8.10 Any decision by Nomad as to:

 

  8.10.1  whether or not to bring any action for breach of any of the Warranties or clause 8.11 on behalf of a person deriving title to the Placing Shares; and

 

  8.10.2  the identity of the person against whom such action is brought, shall be entirely at the discretion of Nomad.

 

8.11 If OSI is in breach of any the Warranties contained in paragraphs 9 and/or 23 of Schedule 2, or if the Company is in breach of any of the Warranties contained in paragraphs 9, 10, 14 and/or 23 of Schedule 2 (together the “Indemnified Warranties”), OSI and the Company hereby severally undertake with Nomad (for itself and as trustee for each and every Indemnified Person) to keep each and every Indemnified Person indemnified from and against all losses, claims, liabilities, actions, demands, reasonable costs, charges and expenses which any of the Indemnified Persons may properly suffer or incur (including all such costs, charges and expenses as any such Indemnified Person may pay or incur in responding to, or disputing, any such actions, claims or demands or in enforcing its rights for breach of the Indemnified Warranties) by reason of, resulting from, attributable to or in connection with, directly or indirectly, breach of the Indemnified Warranties.

 

8.12 Collins Stewart hereby confirms and acknowledges to the Company, OSI and the Directors that it has not entered into this Agreement in reliance on any representation or warranty other than those set out in this Agreement.

 

9 Indemnities

 

9.1

No claim shall be made against any Indemnified Persons to recover any loss, damage, cost, charge or expense which the Company or any of the Directors may suffer or incur by reason of or arising out of the carrying out by Nomad or on its behalf of its obligations or services under this Agreement or in connection with the

 

21


 

Placing unless and to the extent that such loss, damage, cost, charge or expense resulted from the negligence, wilful default or fraud of Nomad and/or any other Indemnified Person or a breach by Nomad of its obligations hereunder or of its respective duties and obligations under FSMA, the rules of the FSA or the AIM Rules.

 

9.2 The Company agrees and undertakes with Nomad (for itself and as trustee for each and every other Indemnified Person) to keep each and every Indemnified Person indemnified from and against all losses, claims, liabilities, actions, demands, reasonable costs, charges and expenses incurred in any jurisdiction which any of the Indemnified Persons may properly suffer or incur (including all such costs, charges and expenses as any such Indemnified Person may pay or incur in responding to, or disputing, any such actions, claims or demands or in enforcing its rights under this clause 9) by reason of the carrying out by Nomad of its obligations or services under or in connection with this Agreement or the Placing including:

 

  9.2.1  any failure or alleged failure by the Company, or any of its Subsidiaries, agents, employees or professional advisers or any of the Directors to comply with the Act, FSMA, the CREST Regulations (if applicable) or the AIM Rules or any other requirement of statute or statutory regulation in relation to Admission or the Placing; or

 

  9.2.2  the Placing Documents not containing, or being alleged not to contain, all information required to be stated therein by the Act, FSMA, the CREST Regulations (if applicable) or the AIM Rules or any other requirement of statute or statutory regulation in any jurisdiction or any statement therein being, or being alleged to be, untrue, inaccurate, incomplete or misleading or not based on reasonable grounds; or

 

  9.2.3  any misrepresentation or alleged misrepresentation (by whomsoever made) contained in the Placing Documents or any other document issued in connection with Admission or the Placing; or

 

  9.2.4  the carrying out or performance in a proper manner by Nomad of its duties, obligations and services under or in connection with this Agreement and otherwise in connection with Admission or the Placing or the issue and publication of any or all of the Placing Documents or any other document issued in connection with Admission or the Placing; or

 

22


  9.2.5  any breach or alleged breach of the laws or regulations of any country resulting from the distribution of any or all of the Placing Documents or any other document issued by or authorised to be issued by the Company in connection with Admission or the Placing in, into or to such country, being a country in which such acts would be or in contravention of any laws or regulations;

 

  9.2.6  any breach of the confirmation to be delivered to Nomad pursuant to clause 2.1.4; or

 

  9.2.7  the allotment and issue of the Placing Shares,

 

save to the extent that it resulted from the negligence, wilful default or fraud of any such Indemnified Person or the breach by Nomad or any other Indemnified Person of its obligations hereunder or of its duties and obligations under FSMA, the rules of the FSA or the AIM Rules.

 

9.3 Any transaction or step carried out by Nomad pursuant to this Agreement will be carried out at the request of and as agent for the Company and not for Nomad itself. Neither Nomad nor any other Indemnified Person will be responsible for any loss or damage to any person arising from any such transaction or step, or for any insufficiency or alleged insufficiency of the Placing Price or of the terms on which any Placees may be procured by Nomad, or for the timing of any such subscription unless such loss or damage arises from the negligence or wilful default of Nomad or any other Indemnified Person or the breach by Nomad of its obligations hereunder or of its duties and obligations under FSMA, the rules of the FSA or the AIM Rules.

 

9.4 Neither Nomad nor any other Indemnified Person will be responsible to the Company or to the Directors or to any other person responsible for the Admission Document for verifying the accuracy, completeness or fairness of the information contained in the Placing Documents, or otherwise published by the Company in connection with the Placing.

 

9.5 If the United Kingdom HM Revenue and Customs or any other Taxing Authority brings into any charge to taxation any sum payable under the indemnity contained in clause 9.2 or 8.11, the amount so payable shall be grossed up by such amount as will ensure that the Indemnified Person is placed in the same net of tax position as it would have been in had the sum payable under clauses 9.2 or 8.11 not been liable to be brought into charge for any Taxation purposes.

 

23


9.6 As soon as reasonably practicable after Nomad becomes aware of any claim made or threatened within the scope of the indemnities set out in this clause 9, Nomad shall notify the Company of the relevant claim (indicating the nature of the allegations being made) and shall thereafter, subject to any requirement imposed by an insurer of Nomad or any Indemnified Person:

 

  9.6.1  at reasonable intervals keep the Company informed of the progress of the claim;

 

  9.6.2  provide the Company with copies of such documentation relating to the claim as the Company may reasonably request; and

 

  9.6.3  maintain reasonable consultation with the Company regarding decisions concerning the claim;

 

subject in each case to Nomad being indemnified to its reasonable satisfaction against all liabilities, reasonable costs, claims, losses, damages, charges and expenses properly incurred by it in consequence of its compliance with this clause 9.6 and provided that nothing in this clause 9 shall:

 

  9.6.4  require any Indemnified Person to provide the Company with a copy of any document which it, in good faith, considers to be held by it subject to a duty of confidentiality or to be privileged whether in the context of any litigation connected with the claim or otherwise; or

 

  9.6.5  subject to clause 9.8, prevent any Indemnified Person from settling, compromising or paying the claim, or accepting any original liability in relation thereto and enforcing the indemnity against the Company.

 

9.7 The indemnities contained in this clause 9 shall remain in full force and effect following Admission.

 

9.8 Nomad agrees that it will not without the prior written consent of the Company (not to be unreasonably withheld or delayed) settle or compromise or consent to the entry of any judgement with respect to any pending or threatened claim in respect of which indemnification may be sought by any Indemnified Person under this Clause 9 (whether or not the Indemnified Person is an actual or potential party to such Claim) unless such settlement, compromise or consent includes an unconditional release of the Company from all liability arising out of such claim.

 

24


10 Termination

 

10.1 If at any time before Admission, Nomad becomes aware that:

 

  10.1.1  any statement contained in the Admission Document has become or been discovered to be untrue, inaccurate or misleading or that there has been an omission therefrom; or

 

  10.1.2  any of the Warranties was, when given, untrue or inaccurate; or

 

  10.1.3  any of the Warranties is not, or has ceased to be, true and accurate (or would not be true and accurate if then repeated) by reference to the facts subsisting at the time; or

 

  10.1.4  any of the Directors or the Company have failed to comply with any of their respective obligations under this Agreement; or

 

  10.1.5  a material new factor, mistake or inaccuracy relating to the information included in the Admission Document has arisen such that a Supplementary Admission Document is required by the AIM Rules to be published,

 

then Nomad shall, if it is of the opinion that any such matter, fact, circumstance or event is materially adversely prejudicial in relation to the Placing or the Application (in the context of the Group as whole) and that it is inappropriate to proceed with the Placing or the Application, forthwith consult with the Company and may, during or as soon as practicable following such consultation, by notice in writing to the Company, terminate this Agreement with immediate effect.

 

10.2 If, at any time before Admission, there occurs any change in national or international, military, diplomatic, monetary, economic, political, financial or market conditions which, in the opinion of Nomad arrived at in good faith, would or would be likely to materially adversely prejudice the Company or the Placing, then Nomad may, in its absolute discretion, by notice in writing to the Company, terminate this Agreement with immediate effect.

 

10.3 If this Agreement is terminated under this clause 10:

 

  10.3.1  Nomad shall, on behalf of the Company, withdraw the application (and, if appropriate, request the London Stock Exchange not to make the relevant announcements under rule 6 of the AIM Rules);

 

25


  10.3.2  the Company shall, if so requested by Nomad, make a press announcement in such form as Nomad may reasonably require; and

 

  10.3.3  Nomad shall ensure that all cheques and banker’s drafts received from Placees which have not been presented in respect if the relevant Placing are returned to the relevant Placees and that the proceeds of any cheques or banker’s drafts received from Placees which have been presented (together with other monies received from Placees) are repaid to the relevant Placees.

 

10.4 If this Agreement is terminated under this clause 10, the provisions of clause 2.2 shall apply as if the conditions set out in clause 2.1 had not been fulfilled.

 

11 Fees, commissions and expenses

 

11.1 In consideration of Nomad’s services in connection with the Placing, the Company shall pay to Nomad:

 

  11.1.1  a corporate finance fee of £100,000;

 

  11.1.2  a commission of 4 per cent, of the aggregate amount equal to the Placing Price multiplied by the total number of Placing Shares; and

 

  11.1.3  a further commission of 0.25 per cent, of the aggregate amount equal to the Placing Price multiplied by the total number of Placing Shares in the event that the market capitalisation of the Group on Admission is £120 million or more,

 

together with any VAT payable thereon, which commission and fee shall be paid by the Company in cleared funds not later than 3.00 pm on the date on which Nomad makes payment to the Company pursuant to clause 5.4.

 

11.2 In addition to the fee and commissions referred to in clause 11.1, the Company shall reimburse Nomad (to the extent the same are properly incurred by Nomad) in respect of the reasonable costs, charges and expenses of and incidental to the Application, the Placing and the issue of the Placing Shares, as follows:

 

  11.2.1  up to the sum of £75,000 (plus any VAT payable thereon) in relation to the properly incurred legal fees of Nomad; and

 

  11.2.2 

up to the sum of £40,000 (less an amount equal to all printing costs if the same are not paid by Nomad) incurred in relation to all other

 

26


 

reasonable costs, including without limitation, all printing costs (if such are paid by Nomad), advertising and distribution costs, London Stock Exchange fees, the fees of the Registrars, all accountancy or other professional fees and expenses (except for the legal fees and expenses of Nomad) and all stamp duty and stamp duty reserve tax (if any) payable by the Placees subscribing for Placing Shares pursuant to the Placing Documents (together in all cases with any VAT thereon),

 

and the Company shall reimburse Nomad accordingly.

 

11.3 Any commissions agreed by Nomad to be payable by it to Placees will be paid out of the commission referred to in clause 11.1.2.

 

11.4 All fees, commissions, costs and expenses payable by the Company shall be paid by way of set-off and deduction by Nomad from the amounts payable pursuant to clause 5 if the amounts to be so deducted are known at the time of payment, or otherwise within five Business Days after receipt of the relevant invoice.

 

11.5 Where in pursuance of clause 11.2 a sum (the “relevant sum”) is to be paid or reimbursed by the Company to Nomad in respect of any amount and that amount includes an amount in respect of VAT (the “VAT element”), the Company shall pay an amount to Nomad by reference to the VAT element calculated as follows:

 

  11.5.1  if the relevant sum constitutes for VAT purposes a reimbursement to Nomad of any amount incurred by Nomad for the supply of goods or services (otherwise than within clause 11.5.2), a sum equal to the proportion of the VAT element which Nomad certifies represents irrecoverable input tax in the hands of Nomad, that certificate to be conclusive in the absence of manifest error; or

 

  11.5.2  if the relevant sum constitutes for VAT purposes a disbursement and is a reimbursement of an amount incurred by Nomad as agent for the Company, a sum equal to the whole of the VAT element.

 

11.6 Where a payment or reimbursement by the Company to Nomad in respect of any amount constitutes consideration for any supply of services by Nomad to the Company, the Company shall, in addition to the amounts otherwise payable, pay to Nomad the amount of any VAT charged by Nomad in respect of such supply, that payment to be made within five Business Days of the later of Nomad requesting the same and production by Nomad of an appropriate tax invoice.

 

27


12 Undertakings re overseas securities laws

 

12.1 Each of the Company and Nomad undertakes to the other that it has not (and is not aware that any other person has) registered under the United States Securities Act of 1933 (as amended) or any other legislation of any country or territory outside the United Kingdom any shares in the Company and undertakes not to offer or sell any such shares outside the United Kingdom.

 

12.2 The Company undertakes to Nomad that none of the Company, any of its Subsidiaries and any person acting on its or their behalf has engaged in or will engage in, nor has the Company procured nor will it procure any person to engage in, any directed selling efforts with respect to shares in the Company in the United States of America or any other territory outside the United Kingdom during the period commencing on the date of this Agreement and ending 12 months following the Completion Date.

 

12.3 Nomad undertakes to the Company that neither it nor any Indemnified Person nor any person acting on its or their behalf has engaged in or will engage in, nor has any such person procured nor will it procure any person to engage in, any directed selling efforts with respect to shares in the Company in the United States of America or any other territory outside the United Kingdom during the period commencing on the date of this Agreement and ending 12 months following the Completion Date.

 

12.4 Neither the Company, nor any of its Subsidiaries, nor Nomad, nor any person acting on behalf of any such person has or will:

 

  12.4.1  directly or indirectly, make offers or sales of any security, or solicit offers to buy or sell, or otherwise negotiate in respect of, any security under circumstances that would require the registration of the Placing Shares under the US Securities Act;

 

  12.4.2  engage in any form of general solicitation or general advertising (within the meaning of Rule 502(c) of the US Securities Act) in connection with any offer or sale of Placing Shares in the United States; and

 

  12.4.3  engage in any directed selling efforts (as defined in Regulation S under the US Securities Act) with respect to the Placing Shares.

 

28


13 Announcements

 

13.1 Except as expressly required under this Agreement, neither the Company nor the Directors nor OSI shall make or despatch any public announcement or communication concerning the Company or any member of the Group or in connection with the Placing or the issue of the Placing Shares for the period commencing on the date of this Agreement and ending on Admission without the prior written consent of Nomad as to the content, timing and manner of making or despatch of such.

 

13.2 The Company and the Directors shall use all reasonable endeavours to procure that employees of each member of the Group and advisers to and agents of the Company and any other member of the Group observe the restriction set out in clause 13.1 as if they were parties to this Agreement.

 

14 Variation and waiver

 

14.1 No variation of this Agreement shall be effective unless made in writing and signed by all the parties.

 

14.2 No waiver of any term, provision or condition of this Agreement shall be effective except to the extent made in writing and signed by the waiving party.

 

14.3 No omission or delay on the part of any party in exercising any right, power or privilege under this Agreement shall operate as a waiver by it of any right to exercise it in future or of any other of its rights under this Agreement.

 

15 Time of the essence

 

Time shall be of the essence of this Agreement both as to any time, date or period mentioned in this Agreement and to any time, date or period substituted by agreement of the parties.

 

16 Law and jurisdiction

 

16.1 This Agreement shall be governed by and construed in all respects in accordance with English law.

 

16.2 The parties submit to the exclusive jurisdiction of the English courts to determine any disputes which may arise out of, under, or in connection with this Agreement and agree that, in respect of any proceedings, process may be served on any of them in the manner specified for notices in clause 17.

 

29


16.3 The rights set out in this clause are in addition to any other manner of service permitted by law.

 

17 Notices

 

17.1 Any notice or other document to be served under this Agreement must be in writing and shall be delivered or sent by pre-paid first class letter post or facsimile transmission to the party to be served at that party’s address set out in this Agreement:

 

  17.1.1  in the case of the Company, OSI or any of the Directors to:

 

12525 Chadron Ave, Hawthorne, CA 90250, USA

Attention: Victor Sze (General Counsel)

 

  17.1.2  in the case of Nomad to:

 

88 Wood Street, London EC2V 7QR

Attention: Tim Mickley

 

or at such other address or number as that party may from time to time notify in writing to each other party to this Agreement.

 

17.2 Any notice or document shall be deemed served:

 

  17.2.1  if delivered, at the time of delivery;

 

  17.2.2  if posted, on the second Business Day after the day of posting; and

 

  17.2.3  if sent by facsimile transmission, at the time of transmission if between the hours of 9.00 am and 5.00 pm on Monday to Friday (other than statutory holidays) or otherwise at 9.00 am on the next succeeding Business Day.

 

17.3 In proving service (without prejudice to any other means):

 

  17.3.1  by post, it shall only be necessary to prove the notice or document was contained in an envelope properly stamped (with first class airmail postage) and posted as provided in this clause; or

 

30


  17.3.2  by facsimile transmission, it shall be necessary to prove that the notice or document was duly received by production of a copy fax bearing the addressee’s automatic record of correct transmission.

 

18 Invalidity

 

The invalidity, illegality or unenforceability of any provision of this Agreement shall not affect the other provisions of this Agreement.

 

19 Counterparts

 

This Agreement may be executed in any number of counterparts and by the several parties on separate counterparts each of which, when so executed, shall be an original, but all counterparts shall together constitute one and the same instrument.

 

20 Survivorship

 

The warranties, indemnities, undertakings, agreements, and provisions contained in this Agreement shall remain in full force and effect notwithstanding completion of the Placing.

 

21 Entire agreement

 

This Agreement (together with the documents entered into under it or at the same time as it) supersedes all prior understanding and agreements (including the engagement letter dated 30 September 2005 between the Company and Nomad) (whether written or oral) relating to its subject matter and contains the entire agreement between the parties relating to its subject matter.

 

22 Assignment

 

This Agreement is personal to the parties and the rights and obligations of the parties may not be assigned or otherwise transferred without the other parties’ written consent. This Agreement shall be binding on each party’s successors, and personal representatives and estates (as the case may be).

 

23 Contracts (Rights of Third Parties) Act 1999

 

Unless the right of enforcement is expressly granted, no party shall have the right to enforce a provision of this Agreement pursuant to the Contracts (Rights of Third Parties) Act 1999.

 

31


24 General

 

24.1 The Company, OSI and each of the Directors will give all such assistance and provide all such information as Nomad shall reasonably require for the purposes of this Agreement and will execute all such documents and do all such acts and things as Nomad may reasonably require in order to give effect to the terms of this Agreement.

 

24.2 Any of the documents in the agreed terms may be amended with the prior approval of Nomad (such approval not be to unreasonably withheld or delayed) and references to such documents in this Agreement shall, where appropriate, be construed as references to such documents as so amended.

 

24.3 All payments provided for in this Agreement shall be made in pounds sterling.

 

24.4 Without prejudice to the foregoing, the Company and each of the Directors accept that, in addition to any remedy or right of action available to it under this Agreement, any Placee will be entitled (as subscribers of the Placing Shares), to the extent that any Placee has subscribed for the Placing Shares, to the same remedies and rights of action against the Company and each of the Directors and to the same extent as any person acquiring any Placing Shares may have on the basis of the Admission Document and any Supplementary Admission Document.

 

This Agreement is entered into on the date above.

 

32

Relationship Agreement

Exhibit 10.4

 

DATED 24 October 2005

 

SPACELABS HEALTHCARE, INC.

 

OSI SYSTEMS, INC.

 

RELATIONSHIP AGREEMENT

 

in respect of

 

SPACELABS HEALTHCARE, INC.

 

LOGO

 

Adelaide House London Bridge London EC4R 9HA

Tel +44 (0) 20 7760 1000 Fax +44 (0) 20 7760 1111


DATED 24 October 2005

 

PARTIES

 

1 Spacelabs Healthcare, Inc. (a corporation incorporated under the laws of the State of Delaware, USA whose principal place of business is at 5150 220th Avenue SE, Issaquah, Washinton 98029, USA) (the “Corporation”);

 

2 OSI Systems, Inc. (a corporation incorporated under the laws of the State of California, USA INC of 12525 Chadron Ave, Hawthorne CA 90250 USA)(the “Shareholder”).

 

RECITALS

 

A The Corporation has applied to AIM for the admission of the whole of its issued and to be issued shares of common stock to be admitted to trading.

 

B The Shareholder is a company incorporated in the State of California, USA and is listed on NASDAQ. The Corporation is bound by the laws of the State of Delaware, USA.

 

C Prior to the date of this Agreement and on Admission, the Shareholder will be a Controlling Shareholder of the Corporation.

 

D The parties wish to ensure, for so long as the Shareholder (and/or any of its Associates) remains a Controlling Shareholder, the ability of the Corporation to carry out its business independently of the Shareholder (and/or any of its Associates) and on arm’s length terms, and to regulate all and any transactions involving both parties in the best interests of each of the Shareholder and the Corporation respectively.

 

OPERATIVE PROVISIONS

 

1 Definitions and interpretation

 

1.1 The following definitions apply:

 

AIM    AIM, a market operated by the London Stock Exchange plc;
Admission    admission of the whole of the issued and to be issued shares of common stock of the Corporation to trading on AIM;

 

1


Associates    means in relation to the Shareholder:
    

(a)    any other company which is its subsidiary or holding company;

    

(b)    any company whose directors are obliged to act in accordance with the Shareholder’s directions or instructions;

    

(c)    any director of the Shareholder; or

    

(d)    any trustee or nominee of any of the persons detailed in paragraph (a) to (c) above;

     for the time being and in each case other than the Corporation or any subsidiary of the Corporation;
Controlling Shareholder    means a shareholder that is entitled to exercise or to control the exercise of 30 per cent. or more of the rights to vote at general meetings of the Corporation;

 

2


Independent Directors    directors (who may, for the avoidance of doubt be executive directors or non-executive directors) from time to time of the Corporation who are not and who have never been, directly or indirectly, employees or directors of the Shareholder and/or any of its Associates and are free from any business or other relationship which could materially interfere with the exercise of their independent judgement as directors of the Corporation provided always that the right to exercise options over stock in the capital of the Corporation or any stockholding in the Corporation shall not be regarded for the purposes of this Agreement as precluding a director from being an Independent Director;
Shares    the shares of common stock in the capital of the Corporation beneficially owned by or under the direct or indirect control of the Shareholder; and
Voting Rights    the voting rights of the Shareholder and/or any of its Associates attaching to any Shares or otherwise, whether relating to the board of directors or as a stockholder.

 

1.2 Unless otherwise stated, a reference to a recital, clause or sub-clause is a reference to a recital, clause or sub-clause of, this agreement and a reference to this agreement includes its recitals.

 

1.3 Clause headings in this agreement are for ease of reference only and do not affect its construction.

 

1.4 A company is a “subsidiary” of another company, its “holding company”, if that other company:

 

  1.4.1  holds a majority of the voting rights in it; or

 

  1.4.2   is a member of it and has the right to appoint or remove a majority of its board of directors; or

 

3


  1.4.3   is a member of it and controls alone, pursuant to an agreement with other stockholders or members, a majority of the voting rights in it; or

 

  1.4.4  is a subsidiary of a company which is itself a subsidiary of that other company.

 

2 Condition

 

2.1 The obligations of the parties under this agreement are conditional on Admission becoming effective not later than 8.30 am on 8 November 2005 or such later time or date agreed between the parties.

 

2.2 If Admission has not become effective in accordance with clause 2.1, this agreement shall lapse and be of no further effect.

 

3 Undertakings

 

3.1 For so long as the Shareholder and/or any of its Associates constitutes a Controlling Shareholder, the Shareholder shall (and shall, if applicable, procure that each of its relevant Associates shall) at all times and subject to applicable laws exercise its Voting Rights so as to procure, insofar as it is able to do so by the exercise of those rights and powers of control, that:

 

  3.1.1  the Corporation is capable at all times of carrying on its business independently of the Shareholder and, if applicable, its relevant Associates;

 

  3.1.2  all transactions, agreements or arrangements entered into between (1) the Corporation and (2) the Shareholder and, if applicable, its relevant Associates (or their enforcement, implementation or amendment) will be made at arm’s length and on a normal commercial basis (the parties acknowledging that this agreement has been concluded on that basis);

 

  3.1.3  no variations are made to the Corporation’s certificate of incorporation, by-laws or other constitutional documentation which would be contrary to the maintenance of the Corporation’s ability to carry on its business independently of the Shareholder and its Associates;

 

4


  3.1.4  any director of the Corporation not being an Independent Director will at all times abstain from exercising his voting rights and other powers of control available to him where the interests of the Company and the Shareholder conflict;

 

  3.1.5   the provisions of this Agreement are observed; and

 

  3.1.6  once all inter company resolution procedures are exhausted, any dealings or disputes between the Controlling Shareholder and/or its Associates and the Corporation shall be passed to and dealt with on behalf of the Corporation by a committee comprising only the Independent Directors.

 

3.2 For so long as the Shareholder (and/or any of its relevant Associates) constitutes a Controlling Shareholder, the Shareholder shall (and shall, if relevant, procure that its relevant Associates shall):

 

  3.2.1  not directly undertake any activity which may render the Corporation incapable of carrying on its business independently, or enter into any transactions and relationships between the Corporation and the Shareholder (or its Associates) which are not at arm’s length or on a normal commercial basis; and

 

  3.2.2  not propose or vote in favour of any resolution amending the Corporation’s certificate of incorporation, by-laws or other constitutional documentation unless such resolution is voted in favour of by a majority of the Independent Directors.

 

3.3 The Shareholder confirms that as of the date of this Agreement and so far as it is aware all material agreements or arrangements subsisting between the Corporation and it and its Associates are on arm’s length terms and a normal commercial basis and have been disclosed to the management and board of directors of the Corporation and the Shareholder.

 

3.4 The Corporation confirms that as of the date of this Agreement and so far as it is aware all material agreements or arrangements subsisting between it and the Shareholder and its Associates are consistent with and in conformity with this Agreement.

 

3.5 It is not intended that a third party should have the right to enforce a provision of this Agreement pursuant to the Contracts (Rights of Third Parties) Act 1999.

 

5


4 Termination

 

4.1 Subject to clauses 4.2 and 4.3, this Agreement shall terminate and, except in respect of any prior breach, no party shall have any rights or obligations under it, on the Shareholder and/or any of its Associates, if applicable, ceasing to constitute a Controlling Shareholder.

 

4.2 The provisions of clause 3.2.2 shall cease to have effect upon the Corporation’s directors (acting by majority) adopting any resolution or series of resolutions to:

 

  4.2.1 approve the dual listing or listing on any other recognised investment exchange (including, for the avoidance of doubt, NASDAQ); and

 

  4.2.2 as a result of the resolution(s) referred to in clause 4.2.1 above, amend or replace the by-laws of the Company in connection with such listing or dual listing.

 

4.3 This Agreement shall terminate forthwith and automatically upon any amendment or replacement of the by-laws of the Company as a result of the Company becoming listed or dual listed on any other recognised investment exchange (including for the avoidance of doubt, NASDAQ).

 

5 Waiver

 

5.1 The rights of any party in respect of a breach of this agreement shall not be affected by another party failing to exercise, or delaying in exercising, a right or remedy, or by anything else, except a specific authorised written waiver or release. A single or partial exercise of a right or remedy provided by this agreement or by law does not prevent its further exercise or the exercise of another right or remedy.

 

5.2 Waiver of a breach of a term of this agreement, or of a default under it, does not (i) constitute a waiver of another breach or default or (ii) affect the other terms of this agreement.

 

5.3 The rights and remedies provided in this agreement are cumulative and not exclusive of any other rights or remedies.

 

6 Invalidity

 

If a provision of this agreement is held to be illegal or unenforceable, in whole or in part, under an enactment or rule of law, it shall to that extent be deemed not to form part of this agreement and the enforceability of the remainder of this

 

6


agreement shall not be affected. The parties agree to negotiate in good faith to agree the terms of a mutually satisfactory provision to be substituted for the provision found to be illegal or unenforceable.

 

7 Disclosure

 

The parties to this Agreement agree and acknowledge that this document may be summarised in, and made available for inspection, as referred to in, the admission document to be published by the Corporation in connection with Admission.

 

8 Counterparts

 

8.1 This agreement may be executed in a number of counterparts and by the parties on different counterparts, but shall not be effective until each party has executed at least one counterpart.

 

8.2 Each counterpart, when executed, shall be an original, but all the counterparts together constitute the same document.

 

9 No assignment

 

None of the rights and/or obligations of any of the parties under this agreement may be assigned or transferred to any other person.

 

10 Proper law

 

This agreement shall be governed by and construed in accordance with English law and the parties submit to the exclusive jurisdiction of the competent courts in England.

 

Executed as a deed and delivered by the parties on the date of this agreement.

 

Executed as a deed by Spacelabs Healthcare, Inc.

acting by:

 

Director, duly authorised

/s/ Nikhil Mehta

 

7


Executed as a deed by OSI Systems, Inc.

acting by:

 

Officers, duly authorised

/s/ Victor Sze

 

8